MCS-8 is developed using Jyong Biotech’s core patented pharmaceutical composition technology, which Company believes significantly enhances bioavailability and improves physiological efficacy, ...

Elevated pretreatment levels of LDH and GGT were prognostic for shorter OS in patients with mUM; low albumin, elevated LDH and ALT for shorter TTCS.

Elevated baseline LDH levels predict worse clinical outcomes in heart failure with reduced ejection fraction and modestly ...

Analysis of BRAF mutation status in high-risk malignant melanoma patients having received HD IFNa therapy in adjuvant setting. This is an ASCO Meeting Abstract from the 2012 ASCO Annual Meeting I.

Treatment for stage 3 myeloma is typically divided into phases. The goal is to achieve a deep remission, meaning the cancer is undetectable. This is the first phase. Most patients receive a "triplet" ...

Irinotecan liposome combined with anlotinib as second-line treatment in patients with small cell lung cancer (SCLC). Correlation of LDH and α-HBDH with PFS Spearman's correlation-detailed format. PFS ...